| Message: | 1.Non-Human Primates CapabilityandAutoimmuneDiseasesModelof PharmaLegacy Laboratories (Shanghai) Co., Ltdis favored by the majority of customers love, We have established long-term cooperation with many partner, CDX Model,Humanized micefrom PharmaLegacymeet the needs of our customers. PharmaLegacystrength,abide by contract, keep faith, take quality and credit of contract,obtained the customer trust and praise.
2.PharmaLegacy Laboratories (Shanghai) Co., Ltd has been devoted to study the needs of PharmaLegacy industrial customers, ant tailored to customers demand and solutions. The advantage of PharmaLegacy lies not only in the industry-leading technology and the elite professional team, but also to provide excellent services in Pharmacodynamic evaluation test platform,humanized animal model,antibody research and development servi,and the enthusiasm of positive innovation and faith of respect promise . Become a customer trusted Popular Syngeneic mouse model integrated service providers, to help customers realize the business value of Syngeneic mouse model, is PharmaLegacy unswerving mission and pursuit. Details: Immunotherapeutics fight cancer by taking advantage of a patient's own immune system, therefore, preclinical research into new therapies requires appropriate models with fully functional immunity. Syngeneic mouse model (allografts derived from immortalized mouse cancer cell lines which originated from the same inbred strain of mice) provide a valuable system for assessing new single agent, combination immunotherapies, or combination radiotherapy within mice with fully competent immunity. Pharmalegacy provides a panel of well validated syngeneic mouse models for preclinical immunotherapy research, used to interrogating novel immune-oncology treatments via activating the mouse immune system. We have model types include subcutaneous, orthotopic and metastatic. Our suite of syngeneic mouse model includes 22 models covering 14 cancer types and more on going, |
my account
